China's State FDA Completes Evaluation Of 2010's Select Pharmaceuticals
This article was originally published in PharmAsia News
Executive Summary
China's State FDA has finished testing and evaluating 150 national essential drugs and 39 high-risk drugs selected under its national drug evaluation plan, according to the results of a recent national online conference on the evaluation reports